In vitro evaluation of the potential therapeutic role of Dendropanax morbifera extract in ameliorating osteoporosis and resultant bone impairment using MC3T3-E1 cells
Authors:
- 20 March 2018
- journal article
- research article
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 54 (5) , 346-354
Abstract
Osteoporosis is a widespread musculoskeletal deformity that affects thousands of older people every year, leading to bone abnormalities and ultimately increasing the risk of bone fractures in both genders. It is considered a lethal disease causing death in thousands of people at the late stage of life. Dendropanax morbifera Leveille is a subtropical broad-leaved prevalent species in Korea. Extracts of the leaves, stems, roots, and seeds of D. morbifera have been used in traditional medicine for the treatment of numerous diseases such as diabetes, atherogenesis, skin disorders, and headaches. However, the anti-osteoporosis effects of D. morbifera have not been examined. The primary objectives of this study were to elucidate the anti-osteoporosis effect of D. morbifera extract through an in vitro study using pre-osteoblastic MC3T3-E1 cells. We found that D. morbifera strongly increased the expression of bone metabolic markers such as alkaline phosphatase (ALP) activity, type I collagen (Col-I) level, and mineralization. Additionally, D. morbifera extract also upregulated the mRNA expression levels of osteogenic genes including ALP, osteocalcin (OCN), osterix (Osx), and runt-related transcription factor 2 (Runx2) in MC3T3-E1 cells via upregulation of bone morphogenetic protein 2 (BMP-2)/p38 MAPK/JNK and Smad1/5/8 signaling pathways. Moreover, addition of D. morbifera significantly suppressed the inhibitory effect of SB203580 (p38 inhibitor). In conclusion, the current study demonstrated that D. morbifera extract significantly increased osteoblast differentiation and mineralization in MC3T3-E1 cells by regulating BMP-2/p38/JNK and Smad1/5/8. Our study might be helpful in the discovery and development of new anti-osteoporosis therapeutic agents.Keywords
This publication has 36 references indexed in Scilit:
- Anticomplement activity of polyacetylenes from leaves of Dendropanax morbifera LeveillePhytotherapy Research, 2010
- Antidiabetic effects of dendropanoxide from leaves of Dendropanax morbifera Leveille in normal and streptozotocin-induced diabetic ratsHuman & Experimental Toxicology, 2010
- Plant-derived compounds in clinical trialsDrug Discovery Today, 2008
- Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cellsThe Journal of Nutritional Biochemistry, 2007
- Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone healthPhytotherapy Research, 2006
- Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organismThe International Journal of Biochemistry & Cell Biology, 2005
- Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow cultureJournal of Cellular Biochemistry, 2005
- Activation of p38 Mitogen-Activated Protein Kinase and c-Jun-NH2-Terminal Kinase by BMP-2 and Their Implication in the Stimulation of Osteoblastic Cell DifferentiationJournal of Bone and Mineral Research, 2003
- Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician?Journal of Oral Science, 2003
- In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.Journal of Cell Biology, 1983